Automated Device for Asthma Monitoring and Management in Monitoring Adult Patients With Lung Cancer Undergoing Radiation Therapy
| Status: | Recruiting |
|---|---|
| Conditions: | Lung Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/17/2018 |
| Start Date: | March 20, 2018 |
| End Date: | January 2021 |
| Contact: | Maria Werner-Wasik, MD |
| Email: | maria.werner-wasik@jefferson.edu |
| Phone: | 215-955-5289 |
A Pilot Study Investigating the Feasibility of ADAMM (Automated Device for Asthma Monitoring and Management) in Combination With Electronic Patient-Reported Outcomes in Adult Patients With Lung Cancer
This pilot early phase I trial studies the Automated Device for Asthma Monitoring and
Management in monitoring adult patients with lung cancer who are undergoing radiation
therapy. The Automated Device for Asthma Monitoring and Management may provide useful
information to doctors to help monitor adult patients with lung cancer and diagnose certain
conditions earlier than traditional means.
Management in monitoring adult patients with lung cancer who are undergoing radiation
therapy. The Automated Device for Asthma Monitoring and Management may provide useful
information to doctors to help monitor adult patients with lung cancer and diagnose certain
conditions earlier than traditional means.
PRIMARY OBJECTIVES:
I. Determine compliance with the Automated Device for Asthma Monitoring and Management
(ADAMM) device in patients receiving radiation therapy (RT) for lung cancer.
SECONDARY OBJECTIVES:
I. Evaluate feasibility of recruitment, acceptability of the ADAMM device, and compliance
with electronic patient-reported outcomes (ePROs) in this patient population
I. Determine compliance with the Automated Device for Asthma Monitoring and Management
(ADAMM) device in patients receiving radiation therapy (RT) for lung cancer.
SECONDARY OBJECTIVES:
I. Evaluate feasibility of recruitment, acceptability of the ADAMM device, and compliance
with electronic patient-reported outcomes (ePROs) in this patient population
Inclusion Criteria:
- Patients are capable of giving informed consent
- Patients are eligible to be treated with RT and plan to start treatment
- Patients have either metastatic or non-metastatic lung cancer as defined in history
and physical
- Patients must be able to read or speak English
- Women of reproductive potential should have a negative serum or urine pregnancy test
within one week prior to radiation planning CT scan
Exclusion Criteria:
- Patients who cannot read or speak English
- Patients who are not candidates for RT treatment
- Women of childbearing potential who are pregnant or breastfeeding
We found this trial at
1
site
Philadelphia, Pennsylvania 19107
Phone: 215-955-5289
Click here to add this to my saved trials
